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Strong familial aggregation of schizophrenia has been reported 
but there is uncertainty concerning the degree of genetic con-
tribution to the phenotypic variance of the disease. This study 
aimed to examine the familial aggregation and heritability of 
schizophrenia, and the relative risks (RRs) of other psychi-
atric diseases, in relatives of people with schizophrenia using 
the Taiwan National Health Insurance Database. The study 
population included individuals with affected first-degree 
or second-degree relatives identified from all beneficiaries 
(n = 23 422 955) registered in 2013. Diagnoses of schizophre-
nia made by psychiatrists were ascertained between January 
1, 1996 and December 31, 2013. Having an affected co-twin, 
first-degree relative, second-degree relative, or spouse was 
associated with an adjusted RR (95% CI) of 37.86 (30.55–
46.92), 6.30 (6.09–6.53), 2.44 (1.91–3.12), and 1.88 (1.64–
2.15), respectively. Compared with the general population, 
individuals with one affected first-degree relative had a RR 
(95% CI) of 6.00 (5.79–6.22) and those with 2 or more had a 
RR (95% CI) of 14.66 (13.00–16.53) for schizophrenia. The 
accountability for the phenotypic variance of schizophrenia 
was 47.3% for genetic factors, 15.5% for shared environmen-
tal factors, and 37.2% for non-shared environmental factors. 
The RR (95% CI) in individuals with a first-degree relative 
with schizophrenia was 3.49 (3.34–3.64) for mood disorders 
and 3.91 (3.35–4.57) for delusional disorders. A family his-
tory of schizophrenia is therefore associated with a higher 
risk of developing schizophrenia, mood disorders, and delu-
sional disorders. Heritability and environmental factors each 
account for half of the phenotypic variance of schizophrenia.
Key words:  schizophrenia/heritability/familial 
aggregation/mood disorders/delusional disorders
Introduction
Schizophrenia is a chronic mental disorder presenting 
with positive (delusions, and hallucinations, incoher-
ent speech, and disorganized thinking) and/or negative 
(restricted affect, empty speech content, decreased moti-
vation, and social withdrawal) symptoms.1 Although 
schizophrenia is a mental disease with relatively low 
prevalence it is a leading cause of global attributable 
disease burden.2 The median point estimate of global 
schizophrenia prevalence is approximately 0.5% accord-
ing to a recent systematic review summarizing estimates 
drawn from 46 countries.3 In Taiwan, the prevalence of 
schizophrenia in 2001 was estimated to be 0.64% using 
nationwide data,4 and the direct and indirect economic 
costs of the condition are substantial.5
Ample evidence suggests that schizophrenia is sub-
ject to strong familial predisposition, implying that both 
genetic and shared environmental factors contribute 
significantly to the phenotypic variance of the disor-
der. A population-based study using the Danish registry 
reports several environmental factors, such as urban birth 
and immigration status, which contribute significantly to 
schizophrenia susceptibility.6 Heritability, the degree of 
genetic contribution to phenotypic variance, has been 
estimated to range between 41% and 87%.7–13 In general, 
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heritability estimates derived from twin studies are higher 
than those based on the general population. One estimate 
for heritability based on a meta-analysis of 12 twin stud-
ies was 81%.12 However, an estimate calculated from the 
population-based data of the Swedish Multi-generation 
Register was lower, though still substantial, at 64%.13
The heritability of schizophrenia is high, but only part 
of it can be explained by known associated alleles, sug-
gesting the existence of “missing heritability.” A genetic 
risk profile score based on 108 genetic loci reported by 
a large genome-wide association (GWA) study explained 
only 7% of the variation on the liability scale.14 Another 
GWA study, which enrolled 3322 European individuals 
with schizophrenia and 3587 controls, reported that the 
variance explained by markers that tag the causal alleles 
ranged from 32% to 36%.15 Furthermore, common genetic 
variants underlying schizophrenia and bipolar disorder 
have been reported using the Swedish database.13 Rasic 
et al16 reported a 1.62-fold risk of mood disorders among 
offspring of parents with schizophrenia in a recent meta-
analysis. Offspring of parents with severe mental illness 
(SMI) are at increased risk for a range of psychiatric 
disorders and one-third of them may develop a SMI by 
early adulthood. Evidence for the familial co-aggregation 
of schizophrenia and other psychiatric illnesses has been 
reported rarely in other populations.
The notion of schizophrenia as a highly heritable dis-
ease is supported by current literature, but parameters 
that are important for genetic counseling, such as the 
absolute and relative risk (RR) of the disease, heritabil-
ity, and the proportion of sporadic cases, are lacking for 
the Asian population. The sizable “missing heritabil-
ity” implies either undiscovered genetic associations or 
overestimated heritability. The familial co-aggregation 
between schizophrenia and other mental disorders also 
needs verification.
In previous years, we have developed a nationwide 
genealogy, and linked this to health information derived 
from Taiwan’s National Health Insurance (NHI) Research 
Database. Using the comprehensive health information 
and pedigree data of the entire population, this study aims 
to estimate the RRs of schizophrenia in individuals who 
have affected relatives of specific kinship, and to examine 
the relative contribution of genetic, shared and non-shared 
environmental factors to schizophrenia susceptibility. In 
addition, we estimated the RRs of other psychiatric ill-
nesses associated with a family history of schizophrenia.
Methods
Study Population
This study received ethical approval from the Institutional 
Review Board of the Chang Gung Memorial Hospital (104-
8209B). Our primary data source is the Taiwan NHI data-
base, which contains registration and original claims data 
of all residents in Taiwan. The program achieved in 2013 
the exceptionally high coverage rate of 99.5%.17 Since 1995, 
the NHI Database records gender, date of birth, place of 
residence, details of insurance, family relationships, dates 
of inpatient and outpatient visits, medical diagnoses, medi-
cal expenditures, prescription details, vaccination status, 
examinations, operations, procedures, and fees incurred.
We used the registry of beneficiaries, a part of the 
NHI database, to construct a cohort comprising all NHI 
beneficiaries registered in 2013. Among them, we identi-
fied all patients with schizophrenia, mood disorders and 
delusional disorders from the registry of catastrophic 
illness patients, these diagnoses being ascertained up 
to December 31, 2013. Individuals with a positive fam-
ily history of schizophrenia in 2013 were identified and 
classified according to the particular kinship of affected 
relatives. Individuals without valid insurance status were 
excluded from analysis.
Methods for genealogy reconstruction using recorded 
family relationships in the NHI database are reported 
in our previously published manuscripts.18–20 In brief, 
we rely upon the recorded relationships between the 
insured persons and their dependents to identify family 
relationships. We established family relationships (par-
ents, offspring, full siblings, twins, and spouse) using 
the identifiers and unique personal identification of par-
ents, grandparents, children, grandchildren, and spouse. 
In addition to the direct ascertainment of relationships 
using information recorded in the registry, indirect iden-
tification of parent-offspring relationships was achieved 
using an algorithm.18–20 Full siblings of an individual are 
ascertained if  they had the same parents. Twins are ascer-
tained as full siblings with the same date of birth (±1 d), 
but twin zygosity cannot be derived from the database. 
Among 29 505 197 individuals contained in the registry 
of beneficiaries, 7 856 663 do not have dependents or act 
as dependents, and therefore we could not identify their 
relatives. The rest of the beneficiaries were classified into 
4 042 209 families. The mean family size was 5.4 persons. 
There were 2 to 5 generations in these families. Each indi-
vidual may appear multiple times in different categories 
of family relationships depending on family structure.
Ascertainment of Schizophrenia, Mood Disorders, and 
Delusional Disorders
In Taiwan, patients with suspected mental illnesses are 
referred to psychiatrists for diagnosis and treatment. 
Patients diagnosed with schizophrenia, mood disorders, 
and delusional disorders are entitled to a waiver for medi-
cal co-payment. Clinical information relevant to the diag-
nosis is sent to the NHI Administration for review by 
expert panels to confirm the diagnosis before approval of 
waivers. In Taiwan, schizophrenia, mood disorders, and 
delusional disorders are diagnosed by psychiatrists accord-
ing to the Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition (DSM-IV), which is also used to 
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assist the review of certificate applications for these mental 
disorders.21 The Registry for Catastrophic Illness Patients 
contains all information of patients with schizophrenia 
(International Classification of Disease, 9th Revision 
[ICD-9] code, 295 except 295.8), mood disorders (ICD-9 
code, 296), and delusional disorders (ICD-9 code, 297). We 
used this registry to identify patients with these diagnoses.
Statistical Analysis
We calculated RRs of schizophrenia, mood disorders 
and delusional disorders as the adjusted prevalence ratios 
between the first- or second-degree relatives of an individual 
with schizophrenia and the general population,22 using the 
Breslow-Cox proportional hazards model23,24 with a robust 
sandwich method to handle intra-familial clustering.25 The 
RR was adjusted for age, gender, occupation categories, 
income level quintiles, level of urbanization of residence, 
and family size.13,26 We also conducted age- and sex-adjusted 
models, the results of which were similar to the full model. 
We present these results in the supplementary tables 1–3.
We fitted models separately according to the kinship 
and sex of affected relatives. Twins were excluded from 
the sibling analyses. We also compared the risk of schizo-
phrenia in individuals with 1 or 2 affected first-degree 
relatives with the risk in the general population.
Heritability is the proportion of phenotypic variance 
attributable to genetic factors, and the familial transmis-
sion is the proportion of both genetic and shared envi-
ronmental contribution, both of which are calculated 
using the liability threshold model.27–29 With information 
on background disease prevalence and kinship-specific 
RR for the disease, this model partitions the phenotypic 
variance into genetic and environmental components for 
dichotomous traits such as disease diagnosis.19,30 We used 
the equation developed by Yang et al30 to estimate both the 
familial transmission and heritability. We used the spouse 
as a control to separate genetic and non-shared environ-
mental contributions to phenotypic variance, assuming 
that spouses share no genetics with other blood relatives 
but share the family environment. Therefore, assortative 
mating was not considered in our model. We restricted 
family history to first-degree relatives and assumed an 
average of 2 siblings per family (details of statistical anal-
ysis are shown in the supplementary material).
All statistical hypotheses were tested on the 2-sided 5% 
level of significance. All analyses were performed using 
SAS v. 9.3 (SAS institute).
Results
Schizophrenia Prevalence in Individuals With Affected 
First-degree Family Members vs the General Population
The study population comprised 23 422 955 individu-
als enrolled in NHI in Taiwan in 2013. Among these 
47.45%, 57.45%, 47.29%, and 1.51% had a parent, child, 
sibling, or twin identified, respectively. We identified 
101 189 patients with the diagnosis of schizophrenia, 
giving a crude prevalence of 0.43%. Men had a slightly 
higher prevalence (0.46%) than women (0.40%), with a 
male:female ratio of 1.15:1. Other baseline characteris-
tics are shown in table 1. In 2013, in the general popula-
tion of Taiwan 160 587 (0.7%) individuals had at least 
1 first-degree relative with schizophrenia, specifically: 
64 154 with an affected parent; 50 660 with affected 
offspring; 47 570 with an affected sibling; and 328 with 
an affected twin. The age-specific prevalence of schizo-
phrenia was statistically significantly higher in individu-
als with affected first- and second-degree relatives with 
schizophrenia than in the general population (figure 1).
RRs for Schizophrenia in Individuals With Affected 
First-Degree Relatives
Prevalence (recurrence risk) of schizophrenia in individu-
als with affected first- and second-degree relatives of spe-
cific types are shown in tables 2 and 3, respectively. The RRs 
(95% CIs) for schizophrenia were associated with the degree 
of genetic distance between family relatives. Overall, having 
an affected co-twin (50% or 100% genetic similarity depend-
ing on zygosity), an affected first-degree relative (on average 
50% genetic similarity), an affected second-degree relative 
(on average 25% genetic similarity) or an affected spouse 
(no genetic similarity) was associated with an adjusted RR 
(95% CI) of 37.86 (30.55–46.92), 6.30 (6.09–6.53), 2.44 
(1.91–3.12), or 1.88 (1.64–2.15), respectively. In addition, 
RRs increased with the number of types of affected first-
degree relative. Compared with the general population, indi-
viduals with one type of affected first-degree relative had a 
RR (95% CI) of 6.00 (5.79–6.22), and those with 2 or more 
had a RR (95% CI) of 14.66 (13.00–16.53) for schizophre-
nia. The sex of the affected relative contributed minimally 
to the RR of schizophrenia. For example, the RR (95% CI) 
for individuals with an affected female first-degree relative 
was 6.86 (6.58–7.16), compared to 6.15 (5.88–6.44) for those 
with an affected male first-degree relative. The sex of the 
affected relative contributed to a similar extent to RR for 
schizophrenia in the case of second-degree relatives (table 3). 
The RRs (95% CIs) were: 8.58 (8.15–9.04) for those with 
affected siblings; 7.26 (6.94–7.6) for those with affected par-
ents; 4.06 (3.85–4.27) for those with affected offspring; 2.54 
(1.79–3.60) for those with an affected aunt or uncle; 2.03 
(1.44–2.88) for those with an affected niece or nephew; 2.72 
(1.88–3.94) for those with an affected grandparent; and 2.87 
(1.60–5.16) for those with affected grandchildren.
Familial Resemblance and Heritability of Schizophrenia
Using a liability threshold model, we estimated the 
accountability for phenotypic variance of schizophrenia 
to be 47.3% for genetic factors (heritability), 15.5% for 
shared environmental factors, and 37.2% for non-shared 
environmental factors. Given the parameters estimated 
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previously, the probability of a patient with schizophre-
nia having sporadic disease was 83.3%.
Co-aggregation of Mood Disorders and Delusional 
Disorders
Table 4 presents adjusted RRs (95% CIs) of other psy-
chiatric illnesses in individuals with affected first- and 
second-degree relatives compared to the general popula-
tion. The RR (95% CI) in individuals with an affected 
first-degree relative with schizophrenia was 3.49 (3.34–
3.64) for mood disorders and 3.91 (3.35–4.57) for delu-
sional disorders. For those with an affected second-degree 
relative the RR (95% CI) was 1.55 (1.23–1.96) for mood 
disorders and 3.71 (2.06–6.67) for delusional disorders.
Discussion
Principle Findings
The prevalence of schizophrenia in individuals with an 
affected first-degree relative is 6.3-fold higher, and with 
an affected second-degree relative 2.4-fold higher than in 
the general population, indicating a dose-response rela-
tionship between the risk of schizophrenia and genetic 
distance. This finding is in line with previous twin studies 
reporting a high concordance of schizophrenia. Familial 
factors contribute approximately two-thirds of pheno-
typic variance while genetic factors contribute approxi-
mately half  of total variance. The magnitude of familial 
aggregation and heritability is substantial but is lower 
than estimates reported by previous studies.12,13 We fur-
ther report a higher prevalence of mood disorders and 
delusional disorders in people with a family history of 
schizophrenia. Despite this familial risk, similar to many 
other common complex diseases,19,30 most cases of schizo-
phrenia are expected to be sporadic.
Fig. 1. Age-specific prevalence of schizophrenia in individuals 
with a first-degree (circle), or second-degree (square) relative with 
schizophrenia and in the general population (triangle) in Taiwan 
in 2013.
Table 1. Baseline Characteristics of Individuals With First-Degree Relatives Diagnosed With Schizophrenia and the General Population
Women Men
Variable
With Affected 
FDR
General 
Population P-value
With Affected 
FDR
General 
Population P-value
No. 81 387 11 903 542 80 357 11 519 413
Age, mean (SD), y 41.9 (19.5) 39.5 (20.9) <.0001 41.2 (19.7) 38.6 (21.0) <.0001
Schizophrenia, No. (%) 2539 (3.12) 47 867 (0.40) 2465 (3.07) 53 322 (0.46)
Place of residence, No. (%)
 Urban 24 519 (30.13) 3 694 254 (31.04) <.0001 22 124 (27.53) 3 298 256 (28.63) <.0001
 Suburban 24 106 (29.62) 3 434 164 (28.85) 23 073 (28.71) 3 269 766 (28.38)
 Rural 32 762 (40.25) 4 775 054 (40.11) 35 160 (43.75) 4 951 325 (42.98)
Income levels, No. (%)
 Quintile 1 24 184 (29.71) 2 526 384 (21.22) <.0001 23 676 (29.46) 2 426 365 (21.06) <.0001
 Quintile 2 8800 (10.81) 1 318 491 (11.08) 7671 (9.55) 1 174 855 (10.20)
 Quintile 3 21 106 (25.93) 3 360 952 (28.23) 21 959 (27.33) 3 303 888 (28.68)
 Quintile 4 14 449 (17.75) 2 289 602 (19.23) 13 167 (16.39) 2 104 521 (18.27)
 Quintile 5 12 793 (15.72) 2 398 414 (20.15) 13 836 (17.22) 2 502 208 (21.72)
Occupation, No. (%)
  Dependents of the insured 
individuals
27 449 (33.73) 4 471 275 (37.56) <.0001 20 115 (25.03) 3 704 412 (32.16) <.0001
  Civil servants, teachers, military 
personnel, and veterans
3944 (4.85) 442 845 (3.72) 4743 (5.90) 570 766 (4.95)
  Nonmanual workers and 
professionals
23 343 (28.68) 3 398 109 (28.55) 27 082 (33.7) 3 708 631 (32.19)
 Manual workers 17 837 (21.92) 2 631 992 (22.11) 16 994 (21.15) 2 304 125 (20.00)
 Other 8814 (10.83) 959 321 (8.06) 11 423 (14.22) 1 231 479 (10.69)
Note: FDR, first-degree relative.
Page 5 of 9
Familial Risk and Heritability of Schizophrenia
Comparison With Previous Estimates of Heritability
Heritability reported in this study is in the lower range of 
previously reported estimates. However, measurements 
of schizophrenia heritability may be subject to variation 
in study design, source population, studied kinships, and 
case definitions of schizophrenia. Twin studies have gen-
erally reported high heritability, ranging between 41% 
and 87%.7–12 A study by Lichtenstein et al13 that involved 
a sample of the Swedish population found a slightly 
lower heritability of 64.3%, while our estimate derived 
from the entire population of Taiwan was even lower at 
47.3%. However, our estimate of familial transmission 
of 62.8% is very similar to that reported in the Swedish 
study (68.8%).13 The difference in heritability estimates 
may in part be due to differences in the methods used 
to partition familial transmission into heritability and 
Table 2. Relative Risks (RRs) of Schizophrenia in Individuals With First-Degree Relatives Diagnosed With Schizophrenia Adjusted for 
Age, Sex, and Socioeconomic Status
Type of Affected Relative Sex of Affected Relative Sex of Individual No. of Cases Prevalence (%) RRs (95% CIs)a
Any Male Male 1285 3.20 6.01 (5.62–6.42)
Female 1263 2.57 6.10 (5.78–6.42)
All 2558 3.06 6.15 (5.88–6.44)
Female Male 1298 3.16 5.71 (5.42–6.01)
Female 1438 3.62 7.98 (7.48–8.51)
All 2736 3.39 6.86 (6.58–7.16)
All Male 2465 3.07 5.73 (5.49–5.98)
Female 2539 3.12 6.72 (6.43–7.02)
All 5004 3.09 6.30 (6.09–6.53)
Parent Male Male 268 2.09 6.39 (5.69–7.17)
Female 147 1.25 6.23 (5.32–7.30)
All 415 1.69 6.50 (5.91–7.15)
Female Male 753 3.52 6.41 (6.01–6.84)
Female 542 2.89 8.99 (8.30–9.74)
All 1295 3.23 7.58 (7.20–7.99)
All Male 1006 2.96 6.38 (6.02–6.75)
Female 684 2.25 8.21 (7.65–8.82)
All 1690 2.63 7.26 (6.94–7.60)
Offspring Male Male 184 1.35 2.57 (2.23–2.97)
Female 627 3.51 4.99 (4.63–5.38)
All 811 2.58 4.09 (3.83–4.37)
Female Male 115 1.26 2.35 (1.96–2.81)
Female 452 4.04 5.53 (5.06–6.04)
All 567 2.79 4.31 (3.98–4.67)
All Male 289 1.29 2.44 (2.18–2.73)
Female 1025 3.57 5.03 (4.75–5.33)
All 1314 2.57 4.06 (3.85–4.27)
Sibling Male Male 818 5.80 8.04 (7.41–8.73)
Female 500 3.69 8.55 (7.87–9.29)
All 1318 4.77 8.50 (8.00–9.03)
Female Male 487 4.44 7.47 (6.86–8.14)
Female 439 4.40 11.16 (9.94–12.53)
All 926 4.42 9.14 (8.51–9.82)
All Male 1263 5.09 7.69 (7.24–8.18)
Female 898 3.86 9.36 (8.72–10.05)
All 2161 4.49 8.58 (8.15–9.04)
Twin Male Male 54 36.73 24.6 (17.31–34.95)
Female 2 5.41 12.21 (4.34–34.32)
All 56 30.43 28.85 (21.56–38.61)
Female Male 1 4.17 9.08 (1.29–64.05)
Female 55 45.45 65.93 (51.14–85.01)
All 56 38.62 54.98 (41.92–72.11)
All Male 55 32.16 23.85 (16.95–33.56)
Female 57 36.08 56.67 (44.17–72.69)
All 112 34.04 37.86 (30.55–46.92)
Spouse Female Male 175 1.29 1.45 (1.25–1.68)
Male Female 192 2.05 2.74 (2.38–3.15)
All All 367 1.60 1.88 (1.64–2.15)
Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.
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shared environmental factors. We used the spouse as a 
control, while Lichtenstein analyzed outcomes from 
nuclear, paternal half-sibling, and maternal half-sibling 
families. Our methods could have underestimated herita-
bility due to the effect of assortative mating, which nul-
lifies the assumption of zero genetic correlation between 
spouses.31 However, assortative mating has been found to 
be of minor relevance in family studies,32 although ideally 
this needs confirmation in our population. In addition, 
the fact that the heritability estimate cannot be higher 
than that of familial transmission suggests that only if  
shared environmental factors were nonexistent would 
the heritability of schizophrenia approach previous esti-
mates, while environmental factors such as birth place 
and season seem to account for more population impact 
on the risk of schizophrenia.10 Therefore the environmen-
tal contribution to schizophrenia susceptibility seem to 
be greater than previously thought.
Currently schizophrenia is subject to much miss-
ing heritability since only a fraction of heritability can 
be explained by GWA studies.33 Factors such as a heri-
table epigenetic component or structural variation,34 
Table 3. Relative Risks (RRs) of Schizophrenia in Individuals With Second-Degree Relatives Diagnosed With Schizophrenia Adjusted 
for Age, Sex, and Socioeconomic Status
Type of Affected Relative Sex of Affected Relative Sex of Individual No. of Cases Prevalence (%) RRs (95% CIs)a
Any Male Male 20 0.18 1.64 (0.94–2.88)
Female 30 0.27 2.57 (1.77–3.74)
All 50 0.23 2.16 (1.55–3.01)
Female Male 31 0.23 2.84 (2.00–4.04)
Female 26 0.20 2.55 (1.53–4.24)
All 57 0.21 2.74 (2.03–3.70)
All Male 50 0.20 2.19 (1.61–2.98)
Female 56 0.24 2.58 (1.90–3.52)
All 105 0.22 2.44 (1.91–3.12)
Aunt/uncle Male Male 8 0.13 1.50 (0.75–2.98)
Female 14 0.24 2.89 (1.61–5.17)
All 22 0.19 2.18 (1.35–3.53)
Female Male 8 0.25 3.35 (1.69–6.65)
Female 7 0.23 3.14 (1.52–6.50)
All 15 0.24 3.30 (2.01–5.42)
All Male 16 0.17 2.08 (1.28–3.37)
Female 21 0.24 2.98 (1.89–4.71)
All 37 0.21 2.54 (1.79–3.60)
Niece/nephew Male Male 8 0.80 1.49 (0.75–2.94)
Female 7 1.25 2.20 (1.07–4.54)
All 15 0.96 1.76 (1.07–2.88)
Female Male 10 1.31 2.57 (1.42–4.66)
Female 6 1.54 2.65 (1.21–5.77)
All 16 1.39 2.53 (1.58–4.05)
All Male 17 0.98 1.86 (1.17–2.95)
Female 13 1.37 2.39 (1.40–4.06)
All 30 1.12 2.03 (1.44–2.88)
Grandparent Male Male 3 0.08 2.86 (0.94–8.66)
Female 4 0.11 3.29 (1.24–8.74)
All 7 0.10 3.05 (1.46–6.35)
Female Male 12 0.13 2.73 (1.52–4.91)
Female 10 0.11 2.52 (1.37–4.67)
All 22 0.12 2.63 (1.71–4.03)
All Male 15 0.11 2.76 (1.64–4.63)
Female 14 0.11 2.71 (1.61–4.56)
All 29 0.11 2.72 (1.88–3.94)
Grandchildren Male Male 1 0.28 2.35 (0.33–16.71)
Female 5 0.50 2.04 (0.85–4.88)
All 6 0.44 2.63 (1.19–5.82)
Female Male 3 0.08 3.92 (0.55–27.94)
Female 4 0.11 2.25 (0.86–5.93)
All 7 0.10 3.15 (1.32–7.53)
All Male 4 0.10 2.95 (0.74–11.79)
Female 9 0.20 2.16 (1.13–4.12)
All 11 0.13 2.87 (1.60–5.16)
Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.
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gene–gene interactions among loci,35 and contributions 
from rare variants36 may partly explain missing heritabil-
ity, and in general it is hard to ascertain these factors in 
GWA studies. Another possibility is that the heritability 
of schizophrenia is lower than that estimated previously 
in twin studies and therefore the extent of missing herita-
bility might be overestimated.
Familial Co-aggregation of Schizophrenia and Other 
Mental Disorders
A family history of  schizophrenia is also a risk factor 
for mood and delusional disorders. Although several 
smaller studies have found no association between a 
family history of  schizophrenia and mood disorders,37–39 
more recent studies generally support the theory that 
families with schizophrenia patients are enriched with 
cases of  unipolar40 or bipolar disorder.41 A recent meta-
analysis found an increased risk for a range of  psychiatric 
disorders, including schizophrenia and mood disorders, 
among offspring of  parents with SMI.16 A nationwide 
study from Sweden found that having a parent or sib-
ling with schizophrenia was associated respectively with 
a 5.2- and 3.7-fold increased risk of  bipolar disorder. 
In addition to epidemiological evidence, data from the 
International Schizophrenia Consortium (ISC) case-
control sample, which genotyped 3322 European indi-
viduals with schizophrenia and 3587 controls, found 
substantial shared genetic liability between schizophre-
nia and bipolar disorder.15 Furthermore, the genetic cor-
relation is estimated to be 0.68 between schizophrenia 
and bipolar disorder, and 0.43 between schizophrenia 
and major depression.42 Previous evidence for familial 
co-aggregation between schizophrenia and delusional 
disorders is insufficient and conflicting.43–45 Our data 
support the co-aggregation of  schizophrenia with both 
mood disorders and delusional disorders. This suggests 
that these other psychiatric illnesses share part of  the 
pathogenesis of  schizophrenia.
Limitations
There are several limitations to the present study. 
Firstly, the case definitions are based purely on the diag-
nosis recorded in the Registry for Catastrophic Illness 
Patients. Detailed information on patients’ clinical 
findings is not available in the database, therefore we 
cannot validate the diagnoses. Nevertheless, our case 
definitions are based on a psychiatrist-made diagnosis 
that is corroborated by an expert panel so we consider 
these case definitions to be stringent. Secondly, the 
zygosity of  twins is not recorded in the database so we 
cannot estimate heritability using a classic twin study 
design. Thirdly, because we estimated heritability using 
the liability threshold model the results are subject to 
the assumption that diseases result from underlying 
liability that is normally distributed in the population. 
Although this is a potential caveat, a previous study 
of  other mental diseases supports the validity of  this 
model and the application of  this model to mental dis-
eases.46 Additionally, recent GWA studies strongly sup-
port the polygenic basis of  schizophrenia.15,47 Fourthly, 
we could not account for the effects of  assortative mat-
ing. If  these effects are not negligible, heritability could 
have been underestimated. Patients with schizophrenia 
also tend to have fewer offspring, and we adjusted the 
family size to account for this effect. Fifthly, this study 
was restricted to Taiwan, and it is possible that differ-
ent results would be obtained in different populations 
and environments. Therefore, further studies in other 
Table 4. Relative Risks (RRs) of Mood and Delusional Disorders in Individuals With First-Degree Relatives Diagnosed With 
Schizophrenia Adjusted for Age, Sex, and Socioeconomic Status
Psychiatric Illnesses Sex
With Affected Relatives General Population
RRs (95% CIs)aNo. of Cases Prevalence (%) No. of Cases Prevalence (%)
With first-degree relatives diagnosed with schizophrenia
 Mood disorders Male 835 1.04 29 693 0.24 3.52 (3.29–3.77)
Female 1264 1.55 48 905 0.41 3.43 (3.25–3.62)
All 2099 1.30 78 598 0.33 3.49 (3.34–3.64)
 Delusional disorders Male 61 0.08 2328 0.02 3.42 (2.67–4.38)
Female 93 0.11 2752 0.02 4.31 (3.52–5.26)
All 154 0.10 5080 0.02 3.91 (3.35–4.57)
With second-degree relatives diagnosed with schizophrenia
 Mood disorders Male 32 0.13 29 693 0.24 1.73 (1.21–2.46)
Female 39 0.08 48 905 0.41 1.42 (1.04–1.93)
All 71 0.15 78 598 0.33 1.55 (1.23–1.96)
 Delusional disorders Male 6 0.03 2328 0.02 4.33 (1.82–10.31)
Female 5 0.02 2752 0.02 2.99 (1.35–6.62)
All 11 0.02 5080 0.02 3.71 (2.06–6.67)
Note: aAdjusted for age, gender, place of residence, quintiles of income levels, occupation, and family size.
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countries are required to determine the generalizability 
of  this study’s findings. Furthermore, we reconstructed 
nationwide genealogy based on the family relationships 
that are recorded in the NHI in order to grant eligibil-
ity of  dependent status, therefore the complete ascer-
tainment of  family relationships was not possible since 
some people do not need family relationships to main-
tain NHI eligibility. For example, migrants, foreigners 
living in Taiwan for more than 6 months, people rely-
ing on government subsidies, and Taiwanese citizens 
living overseas are also eligible for NHI. Nevertheless, 
it was possible to ascertain familial relationships in the 
majority of  permanent residents in Taiwan. Also ascer-
tainment of  cases with psychiatric illnesses and family 
relationships are unrelated processes, so any differential 
ascertainment of  schizophrenia cases is expected to be 
minimal. Lastly, residual confounding may exist. We 
adjusted for residence, income, occupation, and family 
size,26 which may contribute to the risk of  schizophre-
nia.26 However, other factors, such as level of  education, 
have been implicated as risk factors but these are not 
available in the NHI database so cannot be considered.
Conclusions
This nationwide family study confirms that in Taiwan 
a positive family history of  schizophrenia is one of  the 
strongest risk factors for schizophrenia and other psy-
chiatric illnesses. Differential risk associated with dif-
ferent kinships suggests a strong genetic component 
in susceptibility to schizophrenia. These findings may 
be useful in counseling the families of  schizophrenia 
patients.
Supplementary Material
Supplementary material is available at http://schizophre-
niabulletin.oxfordjournals.org.
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